Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs alendronate plus active vitamin D for prevention of glucocorticoid-induced osteoporosis in systemic autoimmune diseases
jRCT1031210596Active, not recruiting
- Sponsor
- Chiba University Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in glucocorticoid-induced osteoporosis (GIOP) comparing Alendronate monotherapy with Alendronate plus alfacalcidol (2 arms). Started Apr 2022; status: active, not recruiting.
02
Drugs
alendronatealfacalcidol
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on jRCT1031210596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031210596.